Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Circadian misalignment in major depressive disorder.

Emens J, Lewy A, Kinzie JM, Arntz D, Rough J.

Psychiatry Res. 2009 Aug 15;168(3):259-61. doi: 10.1016/j.psychres.2009.04.009.

PMID:
19524304
2.

The impact of anxiety and migraine on quality of sleep in patients with major depressive disorder.

Hsu SC, Wang SJ, Liu CY, Juang YY, Yang CH, Hung CI.

Compr Psychiatry. 2009 Mar-Apr;50(2):151-7. doi: 10.1016/j.comppsych.2008.07.002.

PMID:
19216892
3.

Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.

Kang EH, Lee IS, Chung SK, Lee SY, Kim EJ, Hong JP, Oh KS, Woo JM, Kim S, Park JE, Yu BH.

Psychiatry Res. 2009 Sep 30;169(2):118-23. doi: 10.1016/j.psychres.2008.06.021.

PMID:
19695711
4.

Clinical characteristics of patients with major depressive disorder with and without hypothyroidism: a comparative study.

Mowla A, Kalantarhormozi MR, Khazraee S.

J Psychiatr Pract. 2011 Jan;17(1):67-71. doi: 10.1097/01.pra.0000393848.35132.ff.

PMID:
21266898
5.

Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity.

Zimmermann P, Brückl T, Nocon A, Pfister H, Lieb R, Wittchen HU, Holsboer F, Angst J.

Arch Gen Psychiatry. 2009 Dec;66(12):1341-52. doi: 10.1001/archgenpsychiatry.2009.158.

PMID:
19996039
6.

Altered empathic responding in major depressive disorder: relation to symptom severity, illness burden, and psychosocial outcome.

Cusi AM, Macqueen GM, Spreng RN, McKinnon MC.

Psychiatry Res. 2011 Jul 30;188(2):231-6. doi: 10.1016/j.psychres.2011.04.013.

PMID:
21592584
7.

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.

Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group..

CNS Spectr. 2009 Jun;14(6):299-313.

PMID:
19668121
8.

Implicit and explicit procedural learning in patients recently remitted from severe major depression.

Pedersen A, Küppers K, Behnken A, Kroker K, Schöning S, Baune BT, Rist F, Arolt V, Suslow T.

Psychiatry Res. 2009 Aug 30;169(1):1-6. doi: 10.1016/j.psychres.2008.06.001.

PMID:
19595464
9.

Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.

Pandi-Perumal SR, Moscovitch A, Srinivasan V, Spence DW, Cardinali DP, Brown GM.

Prog Neurobiol. 2009 Aug;88(4):264-71. doi: 10.1016/j.pneurobio.2009.04.007. Review.

PMID:
19454302
10.

Reduced physiologic complexity is associated with poor sleep in patients with major depression and primary insomnia.

Yang AC, Tsai SJ, Yang CH, Kuo CH, Chen TJ, Hong CJ.

J Affect Disord. 2011 Jun;131(1-3):179-85. doi: 10.1016/j.jad.2010.11.030.

PMID:
21195485
11.

Prevalence of major depressive disorder in self-referred patients in a late onset hypogonadism clinic.

Sato Y, Tanda H, Kato S, Onishi S, Nakajima H, Nanbu A, Nitta T, Koroku M, Akagashi K, Hanzawa T.

Int J Impot Res. 2007 Jul-Aug;19(4):407-10.

PMID:
17460698
12.

Migraine predicts self-reported muscle tension in patients with major depressive disorder.

Hung CI, Liu CY, Chen JJ, Wang SJ.

Psychosomatics. 2008 Nov-Dec;49(6):502-10. doi: 10.1176/appi.psy.49.6.502.

PMID:
19122127
13.

Depression in patients with subacute myelo-optico-neuropathy (SMON).

Konishi T, Hayashi K, Hayashi M, Ueno S, Yoshida S, Fujimura H, Funakawa I, Kaido M.

Intern Med. 2008;47(24):2127-31.

14.

The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.

Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.

Eur Neuropsychopharmacol. 2009 Jun;19(6):409-15. doi: 10.1016/j.euroneuro.2009.02.007.

PMID:
19327969
15.

Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.

Kishi T, Kitajima T, Ikeda M, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Ozaki N, Iwata N.

Neuropsychobiology. 2009;59(4):234-8. doi: 10.1159/000226612.

PMID:
19571598
16.

Factors associated with concomitant psychotropic drug use in the treatment of major depression: a STAR*D Report.

Shelton RC, Hollon SD, Wisniewski SR, Alpert JE, Balasubramani GK, Friedman ES, Rush AJ, Trivedi MH, Preskorn SH.

CNS Spectr. 2009 Sep;14(9):487-98.

PMID:
19890231
17.

Cortical mechanisms of the symptomatology in major depressive disorder: a resting EEG study.

Lee TW, Yu YW, Chen MC, Chen TJ.

J Affect Disord. 2011 Jun;131(1-3):243-50. doi: 10.1016/j.jad.2010.12.015.

PMID:
21256600
18.

Sleep and circadian rhythm disturbances in bipolar disorder: an urgent need for objective assessment and systematic follow-up.

Kapczinski F, Frey BN, Vieta E.

J Clin Psychiatry. 2011 May;72(5):724. doi: 10.4088/JCP.11l06850. No abstract available.

PMID:
21658357
19.
20.

Diurnal mood variation in depression: a signal of disturbed circadian function?

Murray G.

J Affect Disord. 2007 Sep;102(1-3):47-53.

PMID:
17239958
Items per page

Supplemental Content

Support Center